SCHEMBL4864644

SCHEMBL4864644

COc1ccc(Cn2nc(N3CCN(C(=O)OC(C)(C)C)CC3)c3c(Oc4ccc([AsH2])cc4F)ccnc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 4/20 0.40
GALR2 O43603 1/20 0.40
GALR1 P47211 1/20 0.40
KDM1A O60341 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CCNT1 O60563 1/20 0.38
CDK9 P50750 1/20 0.38
P2RX7 Q99572 1/20 0.36
GPR119 Q8TDV5 6/20 0.36
TLR7 Q9NYK1 2/20 0.36
CFTR P13569 1/20 0.36
SLC2A1 P11166 1/20 0.35
ALDH1A1 P00352 1/20 0.35
SMPD3 Q9NY59 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3097478 0.91 KDM1A (0.41) TLR9GALR2GALR1KDM1ALMNA
SCHEMBL3108841 0.89 GALR2 (0.44) TLR9GALR2GALR1KDM1ALMNA
SCHEMBL3108033 0.83 AOC3 (0.38) TLR9GALR2GALR1KDM1ALMNA
SCHEMBL3095300 0.81 AXL (0.53)
SCHEMBL3106580 0.79 MET (0.45) TLR9GALR2GALR1LMNAMAPT
SCHEMBL3106664 0.79 ALDH1A1 (0.45) GALR2GALR1KDM1AGPR119ALDH1A1
SCHEMBL3099944 0.79 AXL (0.51)
SCHEMBL3101367 0.79 ALDH1A1 (0.41) KDM1AMAPTALDH1A1
SCHEMBL1945933 0.78 KDM1A (0.39) KDM1AGPR119SLC2A1ALDH1A1
SCHEMBL1944319 0.78 GPR119 (0.41) KDM1AGPR119ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2001880-A2 HETEROBICYCLIC PYRAZOLE COMPOUNDS AND METHODS OF USE Array Biopharma, Inc. (US) 2008-12-17 EP disclosed
WO-2007103308-A2 HETEROBICYCLIC PYRAZOLE COMPOUNDS AND METHODS OF USE ARRAY BIOPHARMA INC. (US) 2007-09-13 WO disclosed